ClinicalTrials.govpublic full text
TACE Combinated With Sorafenib in Treating Patients With Unresectable Hepatocellular Carcinoma
phenytoin/sorafenib [va drug interaction], carcinoma, hepatocellular, hepatocellular carcinoma, transarterial chemoembolization, sorafenib, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 804237
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.